Qiagen NV | QIA - Pre Tax Profit

Stock Price
35.26
Daily Change
-0.34 -0.96%
Monthly
-13.98%
Yearly
-2.97%
Q1 Forecast
35.13

Qiagen NV reported $134.73M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
argenx SE USD 386.05M 99.15M Sep/2025
Avita Medical AUD -11.64M 12.13M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
IQVIA Holdings USD 6.16B 5.84B Sep/2025
Moderna USD -187M 631M Sep/2025
Organon & Co USD 243M 14M Sep/2025
Qiagen NV USD 134.73M 7.91M Sep/2025
Revvity USD 55.68M 115.97M Sep/2025
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Viatris USD -7.9M 209.2M Sep/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025